Results 161 to 170 of about 168,766 (175)
Some of the next articles are maybe not open access.

Continuous ambulatory peritoneal dialysis: three-year experience at one center.

Annals of Internal Medicine, 1980
Three years of clinical experience with continuous ambulatory peritoneal dialysis are summarized. Serum urea nitrogen, creatinine, hematocrit, nerve conduction velocity, calcium, inorganic phosphorus, serum proteins, and electrolytes have been maintained
K. Nolph   +6 more
semanticscholar   +1 more source

Early Initiation of Continuous Ambulatory Peritoneal Dialysis in Patients Undergoing Surgical Implantation of Tenckhoff Catheters

Peritoneal Dialysis International, 2011
♦ Background: Nephrologists commonly recommend continuous ambulatory peritoneal dialysis (CAPD) with break-in periods of at least 2 weeks. We investigated the safety and feasibility of shorter break-in periods following surgical implantation of Tenckhoff
Ya-fei Yang   +4 more
semanticscholar   +1 more source

Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients.

American Journal of Kidney Diseases, 2002
Many hemodialysis patients suffer from constipation. The frequency of constipation has not been rigorously evaluated in continuous ambulatory peritoneal dialysis (CAPD) patients, however.
G. Yasuda   +6 more
semanticscholar   +1 more source

Clinical Efficacy and Morbidity Associated with Continuous Cyclic Compared with Continuous Ambulatory Peritoneal Dialysis

Annals of Internal Medicine, 1994
Peritoneal dialysis has been used to treat chronic renal failure since 1962 [1], but it was not until the introduction of continuous ambulatory peritoneal dialysis by Popovich and associates [2] in 1976 that peritoneal dialysis was recognized as an ...
C. D. de Fijter   +6 more
semanticscholar   +1 more source

Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.

New England Journal of Medicine, 1982
Twenty diabetics with end-stage renal disease who had never previously received dialysis treatment were treated with continuous ambulatory peritoneal dialysis for periods of two to 36 months (average, 14.5).
P. Amair   +11 more
semanticscholar   +1 more source

Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.

Archives of Internal Medicine, 1982
In a population of 44 patients receiving continuous ambulatory peritoneal dialysis (CAPD) for a total of 591 patient months, there were 104 episodes of peritonitis.
R. Krothapalli   +6 more
semanticscholar   +1 more source

Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.

American Journal of Clinical Nutrition, 1982
Free amino acid losses into dialysate during a 24-h collection period and postabsorptive plasma amino acid concentrations were measured in 14 studies in nine clinically stable men undergoing continuous ambulatory peritoneal dialysis.
J. Kopple   +4 more
semanticscholar   +1 more source

Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis.

Nephron, 1980
Dialysate effluent protein content was measured in 22 patients undergoing continuous ambulatory peritoneal dialysis (9 with and 13 without previous peritonitis).
A. Katirtzoglou   +5 more
semanticscholar   +1 more source

Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure

European Journal of Heart Failure, 2012
Continuous ambulatory peritoneal dialysis (CAPD) has been proposed as an additional therapeutic resource for patients with advanced congestive heart failure (CHF).
J. Núñez   +11 more
semanticscholar   +1 more source

Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.

Annals of Internal Medicine, 1983
Fungal peritonitis is a rare complication in patients on continuous ambulatory peritoneal dialysis. We report five recent cases and their management. The fungi isolated were Candida albicans, C.
C. Kerr   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy